{
    "Trade/Device Name(s)": [
        "BD Directigen EZ Flu A + B Assay",
        "BD Directigen M EZ Flu A + B Assay"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K101529",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063689",
        "K042472"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "May 28, 2010",
    "Summary Letter Received Date": "June 2, 2010",
    "Submission Date": "May 28, 2010",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza Virus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "immunology"
    ],
    "Analyte(s)": [
        "Influenza A viral antigen",
        "Influenza B viral antigen"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal washes",
        "Nasopharyngeal aspirates",
        "Nasopharyngeal swabs",
        "Throat swabs"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for BD Directigen EZ Flu A + B Assay, a rapid chromatographic immunoassay to qualitatively detect influenza A and B antigens in respiratory specimens",
    "Indications for Use Summary": "Rapid chromatographic immunoassay for direct and qualitative detection of influenza A and B viral antigens from nasopharyngeal washes/aspirates, nasopharyngeal swabs, and throat swabs of symptomatic patients to aid in the diagnosis of influenza A and B infections",
    "fda_folder": "Microbiology"
}